Page last updated: 2024-08-21

pyrazines and Congenital Erythropoietic Porphyria

pyrazines has been researched along with Congenital Erythropoietic Porphyria in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blouin, JM; Costet, P; de Verneuil, H; Duchartre, Y; Ged, C; Lain, A; Lalanne, M; Millet, O; Richard, E1

Other Studies

1 other study(ies) available for pyrazines and Congenital Erythropoietic Porphyria

ArticleYear
Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.
    Proceedings of the National Academy of Sciences of the United States of America, 2013, Nov-05, Volume: 110, Issue:45

    Topics: Animals; Blotting, Western; Boronic Acids; Bortezomib; Circular Dichroism; DNA Primers; Erythroid Cells; Humans; Mice; Models, Molecular; Mutation, Missense; Porphyria, Erythropoietic; Porphyrins; Proteasome Inhibitors; Protein Folding; Pyrazines; Real-Time Polymerase Chain Reaction; Spectrometry, Fluorescence; Uroporphyrinogen III Synthetase

2013